Tango Therapeutics, Inc. (TNGX)
22.48
-0.36
(-1.58%)
USD |
NASDAQ |
Sep 01, 11:47
Tango Therapeutics Cash and Short Term Investments (Quarterly) : 1.014B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.014B |
| March 31, 2026 | 379.84M |
| December 31, 2025 | 343.57M |
| September 30, 2025 | 153.24M |
| June 30, 2025 | 181.21M |
| March 31, 2025 | 217.15M |
| December 31, 2024 | 257.92M |
| September 30, 2024 | 293.28M |
| June 30, 2024 | 322.11M |
| March 31, 2024 | 343.60M |
| December 31, 2023 | 337.74M |
| September 30, 2023 | 360.74M |
| June 30, 2023 | 311.51M |
| Date | Value |
|---|---|
| March 31, 2023 | 333.64M |
| December 31, 2022 | 366.70M |
| September 30, 2022 | 393.86M |
| June 30, 2022 | 416.92M |
| March 31, 2022 | 450.45M |
| December 31, 2021 | 485.82M |
| September 30, 2021 | 503.80M |
| June 30, 2021 | 0.5829M |
| March 31, 2021 | 1.258M |
| December 31, 2020 | 190.32M |
| September 30, 2020 | 1.552M |
| June 30, 2020 | 0.025M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 3.938B |
| Erasca, Inc. | 268.74M |
| NovelStem International Corp. | 0.0562M |
| Brainstorm Cell Therapeutics, Inc. | 0.022M |
| Summit Therapeutics, Inc. | 691.00M |